These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3910774)

  • 21. Evaluation of the effect of indapamide on moderate benign essential hypertension complicated by airways obstruction.
    Bhalla KK
    Postgrad Med J; 1981; 57 Suppl 2():34-6. PubMed ID: 7322957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the efficacy and safety of trandolapril and captopril for 16 weeks in mild-to-moderate essential hypertension. Investigator Study Group.
    Pauly NC; Safar ME
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S73-6. PubMed ID: 7527106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease.
    Anavekar SN; Barter C; Adam WR; Doyle AE
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S374-7. PubMed ID: 6184571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Captopril in the treatment of mild cardiac insufficiency in combination with arterial hypertension].
    Ol'binskaia LI; Morozova TE
    Ter Arkh; 1987; 59(4):103-6. PubMed ID: 3296282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ramipril effects on 24 hour profile of blood pressure in patients with mild and moderate hypertension].
    Kukushkin SK; Lebedev AV; Manoshkina EM; Shamarin VM
    Ter Arkh; 1998; 70(9):69-71. PubMed ID: 9821232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Captopril in treatment-resistant hypertension (author's transl)].
    Studer A; Lüscher T; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1980 Dec; 110(51):1987-91. PubMed ID: 7025191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A clinical study of the verapamil and captopril combination in hypertensive patients uncontrolled by monotherapy. An evaluation by recording the 24-hour ambulatory blood pressure].
    Mora-Macià J; Ocón Pujadas J; Fernández Vidal P; Garrido García J; Velasco Quintana J; del Río Pérez G
    Med Clin (Barc); 1993 Apr; 100(14):526-30. PubMed ID: 8469038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Life quality in patients under hypotensive treatment.
    Pupita F; Ansuini R; Belogi M; Campolucci G; Gaggi S; Pupita G
    Int J Clin Pharmacol Res; 1987; 7(1):13-7. PubMed ID: 3294614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinicofunctional features of arterial hypertension in chronic broncho-obstructive syndrome].
    Zadionchenko VS; Kuz'micheva NV; Sviridov AA; Ol'kha RP; Kashcheeva EV
    Ter Arkh; 2000; 72(1):51-5. PubMed ID: 10687208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacologic effects of peripheral vasodilators in patients with secondary pulmonary hypertension].
    Kukes VG; Tsoĭ AN; Abrosimov AG; Nasyrov ShN; Belov AM
    Klin Med (Mosk); 1989 May; 67(5):52-6. PubMed ID: 2671486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Captopril as a replacement for multiple therapy in hypertension: a controlled study.
    Yodfat Y; Fidel J; Bloom DS
    J Hypertens Suppl; 1985 Nov; 3(2):S155-8. PubMed ID: 3910775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness of captopril in severe hypertension (author's transl)].
    Elkik F; Monteiro A; Corvol P; Milliez P
    Nouv Presse Med; 1981 Apr; 10(19):1557-63. PubMed ID: 7025845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
    Favrat B; Burnier M; Nussberger J; Lecomte JM; Brouard R; Waeber B; Brunner HR
    J Hypertens; 1995 Jul; 13(7):797-804. PubMed ID: 7594444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
    Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M
    Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influence of pulmonary hemodynamics on right ventricular ejection fraction in chronic obstructive pulmonary disease].
    Steiner S; Peters AJ; Schwalen A; Leschke M; Perings C; Strauer BE
    Pneumologie; 1999 May; 53(5):249-54. PubMed ID: 10414141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of the long-term treatment with losartan and captopril and of the abrupt cessation on circadian blood pressure profile].
    Gorbunov VM; Savina LV; Metelitsa VI; Deev AD
    Eksp Klin Farmakol; 2001; 64(2):45-50. PubMed ID: 11548448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of chronic obstructive pulmonary disease with pulmonary hypertension on both left ventricular systolic and diastolic performance.
    Yilmaz R; Gencer M; Ceylan E; Demirbag R
    J Am Soc Echocardiogr; 2005 Aug; 18(8):873-81. PubMed ID: 16084341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.